Related Experiment Video
Updated: Jan 26, 2026
The Citrobacter rodentium Mouse Model: Studying Pathogen and Host Contributions to Infectious Colitis
Published on: February 19, 2013
The Contribution of Host Cells to Pneumocystis Immunity: An Update
Patricia Otieno-Odhiambo1,2,3, Sean Wasserman4,5, J Claire Hoving6,7,8,9
1AFGrica Medical Mycology Research Unit, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa. OTNPAT001@myuct.ac.za.
Abstract:
Pneumocystis is a ubiquitous atypical fungus that is distributed globally. The genus comprises morphologically similar but genetically heterogeneous species that have co-evolved with specific mammalian hosts as obligate intra-pulmonary pathogens. In humans, Pneumocystis jirovecii is the causative organism of Pneumocystis pneumonia (PCP) in immunocompromised individuals, a serious illness frequently leading to life-threatening respiratory failure. Initially observed in acquired immunodeficiency syndrome (AIDS) patients, PCP is increasingly observed in immunocompromised non-AIDS patients. The evolving epidemiology and persistently poor outcomes of this common infection will require new strategies for diagnosis and treatment. A deeper understanding of host immune responses and of the cells that mediate them will improve the chance of developing new treatment strategies. This brief review provides an update on recent studies on the role of host immunity against Pneumocystis.
Insights
Pneumocystis pneumonia (PCP) affects immunocompromised individuals and requires new diagnostic and treatment strategies. Understanding host immunity is key to improving outcomes for this serious fungal infection.
Area of Science:
- Medical Mycology
- Immunology
- Infectious Diseases
Background:
- Pneumocystis is a global, atypical fungal genus with species co-evolved with mammalian hosts.
- Pneumocystis jirovecii causes Pneumocystis pneumonia (PCP) in immunocompromised humans, leading to respiratory failure.
- PCP incidence is rising in both acquired immunodeficiency syndrome (AIDS) and non-AIDS immunocompromised patients.
Purpose of the Study:
- To review recent studies on host immune responses to Pneumocystis.
- To highlight the need for improved diagnostic and treatment strategies for PCP.
- To emphasize the importance of understanding cellular immunity in combating Pneumocystis infections.
Main Methods:
- Literature review of recent studies on host immunity against Pneumocystis.
- Analysis of evolving epidemiology of Pneumocystis pneumonia (PCP).
- Synthesis of current knowledge on immune cells mediating host defense.
Main Results:
- PCP remains a significant threat, particularly in immunocompromised populations.
- Host immune responses play a critical role in controlling Pneumocystis.
- Current treatment and diagnostic approaches require enhancement.
Conclusions:
- Further research into host immunity is essential for developing novel therapeutic interventions for PCP.
- A comprehensive understanding of immune mechanisms will guide the development of effective treatments.
- Addressing the challenges posed by Pneumocystis necessitates advancements in both diagnosis and treatment.
More Related Videos
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
Related Concept Videos
01:36Humoral Immune Responses
01:23Binet's Contribution to Measures of Intelligence
01:38What is the Immune System?
01:23Wechsler's Contribution to Measures of Intelligence
01:40Cell-mediated Immune Responses
01:23Cells of the Adaptive Immune Response